Search

Roundtable: Response and resilience of the Australian life sciences sector

HomeResourcesRoundtable: Response and resilience of the Australian life sciences sector

As the world emerges from the pandemic, it is critical to reflect on what has been learned and how to make strategic and sustainable investments for the future. Australia must identify and prioritise local investments, co-designed with stakeholders, and collaborating with the global life sciences sector. 

Effective investments have the potential to deliver benefits across the ecosystem, promoting discovery and early-stage research, clinical trials and the delivery of world class healthcare and preventive health for the wellbeing of all Australians. 

Pfizer’s white paper, Response and Resilience: Lessons Learned from Global Life Sciences Ecosystems in the COVID-19 Pandemic, highlights learnings from across the world of the favourable characteristics of the life sciences sector to respond to the COVID-19 challenge. A roundtable was held in Sydney on 25 March 2021 to discuss aspects of Australia’s response to the pandemic.

Related Resources

Want To Find Out More?

Are you interested in learning more about Biointelect, including our current white paper submissions and health policy related work?

Get in touch with our team to discover how we’re advancing healthcare for all and how you can harness our intellect and proven expertise in bringing innovative life science to market.

Eri Nishiuchi

Strategic Development and Business Effectiveness

Eri Nishiuchi holds a Bachelor of Business degree from the University of Technology Sydney. Her expertise lies in health systems analysis and client relationship management within the healthcare and life sciences sectors. She also has experience working with patient organisations.

Throughout her career, Eri has provided competitive landscape research support to pharmaceutical and biotech clients across the Asia Pacific region, achieving one of the top client retention rates in the region. Her multilingual abilities have been instrumental in fostering strong relationships with diverse stakeholders.

Eri joined Biointelect in 2024 in a strategic development and business effectiveness role, where her focus will be on conducting market analysis and improving business processes.

Download Your PDF

To access the PDF, please fill out the form below. Once completed, you’ll be redirected to our folder where you can download all available resources.

Please enable JavaScript in your browser to complete this form.